176 related articles for article (PubMed ID: 19420170)
1. Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus.
Swenson JM; Anderson KF; Lonsway DR; Thompson A; McAllister SK; Limbago BM; Carey RB; Tenover FC; Patel JB
J Clin Microbiol; 2009 Jul; 47(7):2013-7. PubMed ID: 19420170
[TBL] [Abstract][Full Text] [Related]
2. Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Sader HS; Fritsche TR; Jones RN
Antimicrob Agents Chemother; 2006 Jul; 50(7):2330-6. PubMed ID: 16801409
[TBL] [Abstract][Full Text] [Related]
3. Detection of vancomycin-intermediate Staphylococcus aureus with the updated Trek-Sensititre System and the MicroScan System. Comparison with results from the conventional Etest and CLSI standardized MIC methods.
Nadarajah R; Post LR; Liu C; Miller SA; Sahm DF; Brooks GF
Am J Clin Pathol; 2010 Jun; 133(6):844-8. PubMed ID: 20472841
[TBL] [Abstract][Full Text] [Related]
4. Comparison of agar dilution, broth microdilution, E-test, disk diffusion, and automated Vitek methods for testing susceptibilities of Enterococcus spp. to vancomycin.
Kohner PC; Patel R; Uhl JR; Garin KM; Hopkins MK; Wegener LT; Cockerill FR
J Clin Microbiol; 1997 Dec; 35(12):3258-63. PubMed ID: 9399530
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA.
Yusof A; Engelhardt A; Karlsson A; Bylund L; Vidh P; Mills K; Wootton M; Walsh TR
J Clin Microbiol; 2008 Sep; 46(9):3042-7. PubMed ID: 18596146
[TBL] [Abstract][Full Text] [Related]
6. Underestimation of vancomycin and teicoplanin MICs by broth microdilution leads to underdetection of glycopeptide-intermediate isolates of Staphylococcus aureus.
Vaudaux P; Huggler E; Bernard L; Ferry T; Renzoni A; Lew DP
Antimicrob Agents Chemother; 2010 Sep; 54(9):3861-70. PubMed ID: 20547791
[TBL] [Abstract][Full Text] [Related]
7. Validation of Vitek version 7.01 software for testing staphylococci against vancomycin.
Raney PM; Williams PP; McGowan JE; Tenover FC
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):135-40. PubMed ID: 12088621
[TBL] [Abstract][Full Text] [Related]
8. Detection of mecA-mediated resistance using reference and commercial testing methods in a collection of Staphylococcus aureus expressing borderline oxacillin MICs.
Swenson JM; Lonsway D; McAllister S; Thompson A; Jevitt L; Zhu W; Patel JB
Diagn Microbiol Infect Dis; 2007 May; 58(1):33-9. PubMed ID: 17240109
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of vancomycin susceptibility testing for methicillin-resistant Staphylococcus aureus: comparison of Etest and three automated testing methods.
Rybak MJ; Vidaillac C; Sader HS; Rhomberg PR; Salimnia H; Briski LE; Wanger A; Jones RN
J Clin Microbiol; 2013 Jul; 51(7):2077-81. PubMed ID: 23596249
[TBL] [Abstract][Full Text] [Related]
10. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides.
Tenover FC; Lancaster MV; Hill BC; Steward CD; Stocker SA; Hancock GA; O'Hara CM; McAllister SK; Clark NC; Hiramatsu K
J Clin Microbiol; 1998 Apr; 36(4):1020-7. PubMed ID: 9542929
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the detection of methicillin-resistant Staphylococcus aureus with elevated vancomycin minimum inhibitory concentrations within the susceptible range.
Phillips CJ; Wells NA; Martinello M; Smith S; Woodman RJ; Gordon DL
Infect Drug Resist; 2016; 9():87-92. PubMed ID: 27330319
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of antibiotic resistance patterns and reduced vancomycin susceptibilities of methicillin-resistant Staphylococcus aureus isolates: a multi-center study].
Çıkman A; Aydın M; Gülhan B; Parlak M; Gültepe B; Kalaycı Y; Bayındır Bilmen F; Solmaz S; Özekinci T
Mikrobiyol Bul; 2015 Apr; 49(2):240-8. PubMed ID: 26167824
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of vancomycin-intermediate-resistant Staphylococcus aureus in Japan.
Hanaki H; Hososaka Y; Yanagisawa C; Otsuka Y; Nagasawa Z; Nakae T; Sunakawa K
J Infect Chemother; 2007 Apr; 13(2):118-21. PubMed ID: 17458681
[TBL] [Abstract][Full Text] [Related]
14. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus.
Tenover FC; Biddle JW; Lancaster MV
Emerg Infect Dis; 2001; 7(2):327-32. PubMed ID: 11294734
[TBL] [Abstract][Full Text] [Related]
15. Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections.
Hsu DI; Hidayat LK; Quist R; Hindler J; Karlsson A; Yusof A; Wong-Beringer A
Int J Antimicrob Agents; 2008 Nov; 32(5):378-85. PubMed ID: 18701261
[TBL] [Abstract][Full Text] [Related]
16. Different Antimicrobial Susceptibility Testing Methods to Determine Vancomycin Susceptibility and MIC for
Chung HS; Lee M
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453893
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin MIC Distribution among Methicillin-Resistant
Othman HB; Halim RMA; Gomaa FAM; Amer MZ
Open Access Maced J Med Sci; 2019 Jan; 7(1):12-18. PubMed ID: 30740152
[TBL] [Abstract][Full Text] [Related]
18. Discordance of vancomycin minimum inhibitory concentration for methicillin-resistant Staphylococcus aureus at 2
Kuo CF; Lio CF; Chen HT; Wang YT; Ma KS; Chou YT; Chang FC; Tsai SY
PeerJ; 2020; 8():e8963. PubMed ID: 32435531
[TBL] [Abstract][Full Text] [Related]
19. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chang SC; Hsueh PR
J Antimicrob Chemother; 2014 Jan; 69(1):211-8. PubMed ID: 23997017
[TBL] [Abstract][Full Text] [Related]
20. Activity of retapamulin against Streptococcus pyogenes and Staphylococcus aureus evaluated by agar dilution, microdilution, E-test, and disk diffusion methodologies.
Pankuch GA; Lin G; Hoellman DB; Good CE; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2006 May; 50(5):1727-30. PubMed ID: 16641442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
